[Protocol for the study and treatment of primary immune thrombocytopenia: PTI-2018]

Abstract

Primary immune thrombocytopenia, formerly known as immune thrombocytopenic purpura, is a disease for which the clinical and therapeutic management has always been controversial. The ITP working group of the Spanish Society of Paediatric Haematology and Oncology has updated its guidelines for diagnosis and treatment of primary immune thrombocytopenia in children, based on current guidelines, bibliographic review, clinical assays, and member consensus. The main objective is to reduce clinical variability in diagnostic and therapeutic procedures, in order to obtain best clinical results with minimal adverse events and good quality of life.

Keywords: Children; ITP; Immune thrombocytopenic purpura; Infancia; PTI; Primary immune thrombocytopenia; Púrpura trombocitopénica inmune; Trombocitopenia inmune primaria.